| 000 | 00948 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250511175604.0 | ||
| 264 | 0 | _c19930624 | |
| 008 | 199306s 0 0 fre d | ||
| 022 | _a0035-3787 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJost, W H | |
| 245 | 0 | 0 |
_a[Long-term treatment of Lambert-Eaton syndrome by 3, 4 diaminopyridine]. _h[electronic resource] |
| 260 |
_bRevue neurologique _c1992 |
||
| 300 |
_a776-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_a4-Aminopyridine _xadverse effects |
| 650 | 0 | 4 | _aAmifampridine |
| 650 | 0 | 4 | _aElectromyography |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLambert-Eaton Myasthenic Syndrome _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParesthesia _xchemically induced |
| 700 | 1 | _aMielke, U | |
| 700 | 1 | _aForrett-Kaminsky, M C | |
| 700 | 1 | _aSchimrigk, K | |
| 773 | 0 |
_tRevue neurologique _gvol. 148 _gno. 12 _gp. 776-9 |
|
| 999 |
_c1310099 _d1310099 |
||